It's more than a result.
It's a person.

We're Driven To Know.


Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
Custom & Companion Diagnostics

One partner from clinical concept to product commercialization.

Learn more about partnering with us.

Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer

Asuragen expands CE mark of the QuantideX® qPCR BCR-ABL IS Kit and QuantideX® qPCR BCR-ABL minor Kit to include clinical use on the Roche Diagnostics cobas z 480 Analyzer.

Read More

Asuragen Expands Portfolio into Alzheimer’s & Cognitive Impairment Space

Asuragen launches AmplideX® PCR/CE TOMM40 RUO Kit to advance studies of neurodegeneration, dementia progression and Alzheimer’s disease.

Read more

Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio

Expansion of the CE-marked BCR-ABL Portfolio offers high quality, ultra-sensitive Major & minor fusion detection for monitoring CML patients.

Learn more

The Latest from Asuragen

AMP 2017 Workshop: Next-Generation Genotyping of Unstable DNA: Expanding AmplideX® PCR Technology Across Neurodegenerative and Neurodevelopmental Disorders
Back To

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.